Humacyte, Inc. (NASDAQ:HUMA) is one of the 11 Best High Volume Penny Stocks to Buy Now. On March 17, 2026, Humacyte, Inc.

On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod) use in adults as a vascular conduit for extremity arterial injury when ...

Biomaterials are specifically engineered to support tissue, nerve and muscle regeneration across the body, yet physicians and ...

Researchers have successfully implanted a bioengineered tooth implant — that “grows” into the gum and fuses with existing nerves — into the mouths of rats. In a new paper published in the journal ...

Presenters at the American Society of Nephrology (ASN) Kidney Week 2023 highlighted the exciting new technologies that nephrology research has developed to improve patient outcomes, quality of life, ...

As the field of bioengineering continues to advance, scientists are making significant strides in growing organs for transplants. Among the most promising developments is the growth of lungs in the ...

To understand consumers’ attitudes toward a bioengineered crop pesticide for controlling Asian citrus psyllid, researchers ...

A new technology that uses bio-printed "patches" to repair damaged heart tissue has been proven to be safer and more cost-effective for patients than other patches. Researchers from The University of ...

Advocates arguing for greater transparency about the use of GMOs in food scored a minor victory this month after a district court told USDA to re-work the digital disclosure portions of the ...

Neoplants' microbiome system uses advanced science and nature to purify indoor air 30 times more effectively than regular plants, offering a continuous and energy-efficient solution to improve air ...